The approval of commercial human fibrin glue as a sealant and adhesive agent for “colostomy closure, coronary bypass surgery, and splenic repair” by the Food and Drug Administration in 1998 has led to its increased, albeit off-label, use in aesthetic surgical procedures to minimize ecchymosis, edema, and hematoma and to eliminate [...]